Hematological Indices and Sympathetic Block Response in Neuropathic Pain
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent
About this trial
This prospective observational study aims to evaluate the relationship between hematological inflammatory indices and clinical treatment response in patients with neuropathic pain undergoing sympathetic nerve block procedures as part of routine clinical care. Hematological parameters including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AISI), and red cell distribution width (RDW) will be evaluated before and after treatment. The association between changes in these indices and pain outcomes will be analyzed.
Eligibility criteria
Qualifiers
Age ≥18 years
Diagnosis of neuropathic pain based on clinical evaluation
DN4 and/or LANSS scores compatible with neuropathic pain
Undergoing sympathetic nerve block as part of routine clinical treatment
Disqualifiers
Age <18 years
Active infection or acute inflammatory disease
Active malignancy
History of hematological disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
120 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov